A Randomized, Open-label Study to Evaluate the Effect of Daprodustat on Blood Pressure in Subjects With Anemia Associated With Chronic Kidney Disease on Hemodialysis Switched From a Stable Dose of an Erythropoiesis-stimulating Agent
Phase of Trial: Phase II
Latest Information Update: 25 Oct 2018
At a glance
- Drugs Daprodustat (Primary) ; Epoetin alfa
- Indications Anaemia; Hypertension
- Focus Therapeutic Use
- Sponsors GlaxoSmithKline
- 31 Aug 2018 Biomarkers information updated
- 18 Jun 2018 Planned End Date changed from 15 May 2019 to 5 Jun 2019.
- 18 Jun 2018 Planned primary completion date changed from 15 May 2019 to 5 Jun 2019.